Cargando…
原发胸腺黏膜相关淋巴组织淋巴瘤七例报告并文献复习
OBJECTIVE: To reveal clinical features, pathological diagnosis, treatment and prognosis of primary thymic mucosa-associated lymphoid tissue (MALT) lymphoma and review literatures. METHODS: The clinical characteristics, pathological diagnosis, laboratory texts, treatment and prognosis of 7 cases of p...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357913/ https://www.ncbi.nlm.nih.gov/pubmed/32023755 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.01.010 |
_version_ | 1783558753817198592 |
---|---|
collection | PubMed |
description | OBJECTIVE: To reveal clinical features, pathological diagnosis, treatment and prognosis of primary thymic mucosa-associated lymphoid tissue (MALT) lymphoma and review literatures. METHODS: The clinical characteristics, pathological diagnosis, laboratory texts, treatment and prognosis of 7 cases of primary thymic MALT lymphoma identified at the First Affiliated Hospital of Nanjing Medical University from November 2017 to January 2019 were collected and analyzed. RESULTS: Of 7 primary thymic MALT lymphoma cases, six were female. Patients were often asymptomatic and were found mediastinal mass by chest CT. After mediastinal mass resection, pathologist reported a primary thymic MALT lymphoma. Laboratory tests showed all patients were positive for anti-nuclear antibody, anti-Ro52 antibodies and anti-Sjogren’s syndrome A antibodies, and increased erythrocyte sedimentation rate (ESR). Four were diagnosed with Sjogren’s syndrome (SS). After surgery, the patients were given the positron emission tomography computed tomography (PET-CT) scans. All cases received “watch and wait” approach. Up to now, all cases showed good prognoses and none of them relapsed. CONCLUSION: Primary thymic MALT lymphoma was rare, and it was often associated with autoimmune diseases. Such patients who usually had good prognoses should be followed up closely and avoided excessive treatments if there were no indications of intervention. |
format | Online Article Text |
id | pubmed-7357913 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Editorial office of Chinese Journal of Hematology |
record_format | MEDLINE/PubMed |
spelling | pubmed-73579132020-07-16 原发胸腺黏膜相关淋巴组织淋巴瘤七例报告并文献复习 Zhonghua Xue Ye Xue Za Zhi 论著 OBJECTIVE: To reveal clinical features, pathological diagnosis, treatment and prognosis of primary thymic mucosa-associated lymphoid tissue (MALT) lymphoma and review literatures. METHODS: The clinical characteristics, pathological diagnosis, laboratory texts, treatment and prognosis of 7 cases of primary thymic MALT lymphoma identified at the First Affiliated Hospital of Nanjing Medical University from November 2017 to January 2019 were collected and analyzed. RESULTS: Of 7 primary thymic MALT lymphoma cases, six were female. Patients were often asymptomatic and were found mediastinal mass by chest CT. After mediastinal mass resection, pathologist reported a primary thymic MALT lymphoma. Laboratory tests showed all patients were positive for anti-nuclear antibody, anti-Ro52 antibodies and anti-Sjogren’s syndrome A antibodies, and increased erythrocyte sedimentation rate (ESR). Four were diagnosed with Sjogren’s syndrome (SS). After surgery, the patients were given the positron emission tomography computed tomography (PET-CT) scans. All cases received “watch and wait” approach. Up to now, all cases showed good prognoses and none of them relapsed. CONCLUSION: Primary thymic MALT lymphoma was rare, and it was often associated with autoimmune diseases. Such patients who usually had good prognoses should be followed up closely and avoided excessive treatments if there were no indications of intervention. Editorial office of Chinese Journal of Hematology 2020-01 /pmc/articles/PMC7357913/ /pubmed/32023755 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.01.010 Text en 2020年版权归中华医学会所有 http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under a Creative Commons Attribution 3.0 License (CC-BY-NC). The Copyright own by Publisher. Without authorization, shall not reprint, except this publication article, shall not use this publication format design. Unless otherwise stated, all articles published in this journal do not represent the views of the Chinese Medical Association or the editorial board of this journal. |
spellingShingle | 论著 原发胸腺黏膜相关淋巴组织淋巴瘤七例报告并文献复习 |
title | 原发胸腺黏膜相关淋巴组织淋巴瘤七例报告并文献复习 |
title_full | 原发胸腺黏膜相关淋巴组织淋巴瘤七例报告并文献复习 |
title_fullStr | 原发胸腺黏膜相关淋巴组织淋巴瘤七例报告并文献复习 |
title_full_unstemmed | 原发胸腺黏膜相关淋巴组织淋巴瘤七例报告并文献复习 |
title_short | 原发胸腺黏膜相关淋巴组织淋巴瘤七例报告并文献复习 |
title_sort | 原发胸腺黏膜相关淋巴组织淋巴瘤七例报告并文献复习 |
topic | 论著 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357913/ https://www.ncbi.nlm.nih.gov/pubmed/32023755 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.01.010 |
work_keys_str_mv | AT yuánfāxiōngxiànniánmóxiāngguānlínbāzǔzhīlínbāliúqīlìbàogàobìngwénxiànfùxí AT yuánfāxiōngxiànniánmóxiāngguānlínbāzǔzhīlínbāliúqīlìbàogàobìngwénxiànfùxí AT yuánfāxiōngxiànniánmóxiāngguānlínbāzǔzhīlínbāliúqīlìbàogàobìngwénxiànfùxí AT yuánfāxiōngxiànniánmóxiāngguānlínbāzǔzhīlínbāliúqīlìbàogàobìngwénxiànfùxí AT yuánfāxiōngxiànniánmóxiāngguānlínbāzǔzhīlínbāliúqīlìbàogàobìngwénxiànfùxí AT yuánfāxiōngxiànniánmóxiāngguānlínbāzǔzhīlínbāliúqīlìbàogàobìngwénxiànfùxí |